Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 39 checked references that resolve
resolves10.1016/j.jad.2011.08.003Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression
resolves10.2105/AJPH.2013.301394Relations of Depressive Symptoms and Antidepressant Use to Body Mass Index and Selected Biomarkers for Diabetes and Cardiovascular Disease
resolves10.2337/dc11-2055Bidirectional Association Between Depression and Metabolic Syndrome
resolves10.1023/A:1008987409499Major depression and cancer: the 13-year follow-up of the Baltimore Epidemiologic Catchment Area sample (United States)
resolves10.1007/s10552-009-9449-1Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample
resolves10.1017/S0033291705005313Psychological risk factors of incidence of breast cancer: a prospective cohort study in Finland
resolves10.1038/clpt.2009.121Effects of Selective Serotonin Reuptake Inhibitor Therapy on Endothelial Function and Inflammatory Markers in Patients With Coronary Heart Disease
resolves10.1159/000054381Direct Action of Serotonin on Prolactin, Growth Hormone, Corticotropin and Luteinizing Hormone Release in Cocultures of Anterior and Posterior Pituitary Lobes: Autocrine and/or Paracrine Action of Vasoactive Intestinal Peptide
resolves10.1002/hup.1116Hyperprolactinemia associated with psychotropics—a review
resolves10.1200/JCO.2006.07.6356A Prospective Study of Plasma Prolactin Concentrations and Risk of Premenopausal and Postmenopausal Breast Cancer
resolves10.1002/ijc.24537Incidence of cancer and antidepressant medication: Record linkage study
resolves10.1093/pubmed/22.2.155Psychotropic medication use and risk of hormone-related cancers: the New York University women's health study
resolves10.1186/1741-7015-8-90A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: The impact of duration of use, cumulative dose and latency
resolves10.3389/fonc.2012.00177Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer
resolves10.1093/aje/kwq045Body Fatness at Young Ages and Risk of Breast Cancer Throughout Life
resolves10.1002/sim.6793Statistical methods for studying disease subtype heterogeneity
resolves10.1093/aje/kwi301Use of Selective Serotonin Reuptake Inhibitors and the Risk of Breast Cancer
resolves10.1038/sj.bjc.6605996Tricyclic antidepressants and the incidence of certain cancers: a study using the GPRD
resolves10.1192/bjp.bp.114.147629Breast cancer screening in women with mental illness: comparative meta-analysis of mammography uptake
resolves10.1007/s00125-011-2268-4Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults
checked 2026-07-22 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.